Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
New York Composite
Gold
Crude Oil
Local Stocks
Buffalo Local Index
Buffalo Local Index
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries
Arena Pharmaceuticals
(NQ:
ARNA
)
80.10
USD
+3.54 (+4.62%)
Official Closing Price
Updated: 4:58 PM EST, Feb 24, 2021
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
725,600
Open
75.97
Bid (Size)
74.00 (27)
Ask (Size)
82.00 (1)
Prev. Close
76.56
Today's Range
75.97 - 82.25
52wk Range
32.95 - 90.19
Shares Outstanding
49,234,094
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
Top News
More News
Arena Reports Fourth Quarter Financial Results with Strong Liquidity Position and Maintained Pipeline Progress Over the Quarter
February 23, 2021
Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) today provided a corporate update and reported financial results for the fourth quarter and full year ended December 31, 2020.
From
Business Wire News Releases
Arena Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
February 18, 2021
Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) today announced that on February 15, 2021, the Compensation Committee of its Board of Directors granted to eleven new employees inducement stock options to...
From
Business Wire News Releases
Performance
YTD
+6.33%
+6.33%
1 Month
+2.69%
+2.69%
3 Month
+22.29%
+22.29%
6 Month
+17.52%
+17.52%
1 Year
+67.61%
+67.61%
More News
Read More
Arena Pharmaceuticals to Release Fourth Quarter & Full-Year 2020 Financial Results and Provide Corporate Update on February 23
February 16, 2021
From
Business Wire News Releases
Arena Pharmaceuticals Announces Changes to Board of Directors
February 16, 2021
From
Business Wire News Releases
Arena Pharmaceuticals to Present at the J.P. Morgan Healthcare Conference on January 13
December 22, 2020
From
PR Newswire
Arena Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
December 18, 2020
From
PR Newswire
Arena Pharmaceuticals Completes Full Enrollment of Etrasimod Phase 3 ELEVATE UC 52 Trial
February 02, 2021
From
Business Wire News Releases
Recap: Arena Pharmaceuticals Q4 Earnings
February 23, 2021
Tags
BZI/Recaps
Benzinga
ARNA
From
Benzinga
Arena Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
January 22, 2021
From
Business Wire News Releases
Arena Pharmaceuticals Earnings Preview
February 22, 2021
Tags
Market News
ARNA
Earnings
From
Benzinga
Arena Pharmaceuticals Inc (ARNA) Q4 2020 Earnings Call Transcript
February 24, 2021
Tags
Market News
ARNA
From
Motley Fool
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.